Trials in line for potential asthma drugRPL554, a potential drug for providing relief to patients suffering from asthma is undergoing human trials in the near future after it successfully cleared trials on more than 60 people in the year 2008 at the Centre for Human Drug Research (CHDR) in the Netherlands.

The drug is believed to offer a crucial insight to medical practitioners across the globe to treat asthmatic patients. This potential drug for asthma is expected to reach the market in the next 3-5 years after successful completion of initial trials for safety and efficacy.

Some practitioners are of the view that this drug will help them to draw new and improved treatment plans for treating their asthmatic patients.

Comments

comments